Cite
Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status
MLA
Aanchal, Kakkar, et al. “Meningeal Hemangiopericytomas: A Clinicopathological Study with Emphasis on MGMT (O(6) -Methylguanine-DNA Methyltransferase) Promoter Methylation Status.” Neuropathology : Official Journal of the Japanese Society of Neuropathology, vol. 34, no. 4, Oct. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1d1168e59430862aec8a35c191ee90ba&authtype=sso&custid=ns315887.
APA
Aanchal, K., Anupam, K., Prerana, J., Nishant, G., Supriya, M., Mehar Chand, S., Ashish, S., Manmohan, S., Shashank S, K., Pramod Kumar, J., Chitra, S., & Vaishali, S. (2013). Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status. Neuropathology : Official Journal of the Japanese Society of Neuropathology, 34(4).
Chicago
Aanchal, Kakkar, Kumar Anupam, Jha Prerana, Goyal Nishant, Mallick Supriya, Sharma Mehar Chand, Suri Ashish, et al. 2013. “Meningeal Hemangiopericytomas: A Clinicopathological Study with Emphasis on MGMT (O(6) -Methylguanine-DNA Methyltransferase) Promoter Methylation Status.” Neuropathology : Official Journal of the Japanese Society of Neuropathology 34 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1d1168e59430862aec8a35c191ee90ba&authtype=sso&custid=ns315887.